Zymeworks News

Maintaining Hold on Zymeworks: ZW191's Potential Amidst Competitive and Regulatory Hurdles

TipRanksApr 12 06:27 ET

Analysts' Top Healthcare Picks: Zymeworks (ZYME), 89bio (ETNB)

TipRanksMar 13 10:00 ET

Zymeworks Analyst Ratings

BenzingaMar 12 07:16 ET

Buy Rating Affirmed for Zymeworks Amid Positive HERIZON Study Outlook and Robust Commercial Prospects of Zanidatamab

TipRanksMar 12 05:16 ET

Stifel Nicolaus Keeps Their Buy Rating on Zymeworks (ZYME)

TipRanksMar 11 22:05 ET

Zymeworks Analyst Ratings

BenzingaMar 11 06:40 ET

Hold Rating on Zymeworks Amidst Pipeline Adjustments and Clinical Validation Awaited

TipRanksMar 11 00:46 ET

Hold Rating on Zymeworks Amid Anticipation of Future Clinical Trial Outcomes

TipRanksJan 5 06:28 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Avadel Pharmaceuticals (AVDL), Zymeworks (ZYME) and Aclaris Therapeutics (ACRS)

TipRanksNov 13, 2023 06:20 ET

Hold Rating for Zymeworks Amid New Preclinical Candidate, Regained Rights, and Anticipated Pipeline Progress: A Comprehensive Financial Analysis

TipRanksNov 10, 2023 06:30 ET

Zymeworks Analyst Ratings

BenzingaAug 15, 2023 07:13 ET

H.C. Wainwright Sticks to Its Hold Rating for Zymeworks (ZYME)

TipRanksAug 15, 2023 06:36 ET

Zymeworks (ZYME) Receives a Buy From Stifel Nicolaus

TipRanksJun 6, 2023 22:16 ET

Zymeworks (ZYME) Receives a Hold From H.C. Wainwright

TipRanksJun 6, 2023 06:25 ET

HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $8 Price Target

BenzingaJun 6, 2023 06:18 ET

Stifel Nicolaus Remains a Buy on Zymeworks (ZYME)

TipRanksMay 29, 2023 22:16 ET

Zymeworks (ZYME) Gets a Buy From Stifel Nicolaus

TipRanksMay 24, 2023 22:08 ET

What 6 Analyst Ratings Have To Say About Zymeworks

BenzingaMay 18, 2023 10:00 ET

Zymeworks (ZYME) Receives a Hold From SVB Securities

TipRanksMay 11, 2023 12:46 ET

Stifel Adjusts Price Target on Zymeworks to $19 From $18, Maintains Buy Rating

MT NewswiresMay 9, 2023 09:54 ET